PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,643,528 | -2.7% | 919,142 | -0.8% | 0.00% | 0.0% |
| Q2 2023 | $5,801,364 | +32.5% | 926,735 | +1.0% | 0.00% | +33.3% |
| Q1 2023 | $4,378,313 | -43.8% | 917,885 | +2.5% | 0.00% | -50.0% |
| Q4 2022 | $7,794,035 | -30.9% | 895,866 | -5.5% | 0.01% | -33.3% |
| Q3 2022 | $11,280,000 | -3.6% | 947,876 | +15.4% | 0.01% | 0.0% |
| Q2 2022 | $11,702,000 | -9.2% | 821,232 | +32.7% | 0.01% | +12.5% |
| Q1 2022 | $12,886,000 | -6.6% | 618,926 | +3.7% | 0.01% | 0.0% |
| Q4 2021 | $13,790,000 | -5.5% | 596,962 | +21.8% | 0.01% | -20.0% |
| Q3 2021 | $14,600,000 | -7.5% | 489,935 | +6.1% | 0.01% | 0.0% |
| Q2 2021 | $15,779,000 | +141.8% | 461,913 | +132.8% | 0.01% | +100.0% |
| Q1 2021 | $6,526,000 | -46.0% | 198,422 | +1.0% | 0.01% | -44.4% |
| Q4 2020 | $12,084,000 | +69.5% | 196,455 | -2.2% | 0.01% | +50.0% |
| Q3 2020 | $7,128,000 | – | 200,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |